Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,331,200 | 2,224,800 | 2,384,900 | 2,591,300 | 2,913,700 |
| Marketable Securities | 1,278,900 | 1,355,000 | 1,942,700 | 1,269,100 | 1,562,200 |
| Receivables | 1,913,800 | 2,024,900 | 2,133,600 | 2,092,600 | 1,880,500 |
| Inventories | 1,068,600 | 1,027,700 | 952,700 | 858,800 | 804,200 |
| Other current assets | 1,294,600 | 1,210,700 | 1,079,900 | 1,195,400 | 1,221,200 |
| TOTAL | $6,887,100 | $7,843,100 | $8,493,800 | $8,007,200 | $8,381,800 |
| Non-Current Assets | |||||
| PPE Net | 3,411,500 | 3,359,900 | 3,330,700 | 3,281,600 | 3,247,300 |
| Investments And Advances | 3,671,100 | 2,844,700 | 2,406,100 | 2,100,100 | 2,660,900 |
| Intangibles | 8,846,400 | 9,079,300 | 9,134,800 | 9,198,900 | 9,285,200 |
| Other Non-Current Assets | 1,802,800 | 1,807,100 | 2,146,400 | 3,531,400 | 3,659,100 |
| TOTAL | $17,731,800 | $17,091,000 | $17,018,000 | $18,112,000 | $18,852,500 |
| Total Assets | $24,618,900 | $24,934,100 | $25,511,800 | $26,119,200 | $27,234,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 454,900 | 398,400 | 383,900 | 389,000 | 530,800 |
| Accrued Expenses | 3,145,300 | 3,286,200 | 2,486,500 | 2,437,800 | 2,765,800 |
| TOTAL | $3,742,200 | $3,804,000 | $3,447,100 | $4,638,600 | $4,863,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,426,200 | 7,425,000 | 7,423,800 | 4,459,900 | 4,459,000 |
| aiOther Non-Current Liabilities | 1,732,000 | 1,834,800 | 1,825,800 | 1,767,500 | 1,761,600 |
| TOTAL | $10,190,600 | $10,385,600 | $10,775,500 | $8,943,700 | $9,031,400 |
| Total Liabilities | $13,932,800 | $14,189,600 | $14,222,600 | $13,582,300 | $13,895,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,336 | 153,882 | 158,314 | 163,188 | 174,064 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 13,976,300 | 13,961,000 | 14,466,700 | 15,673,100 | 16,455,400 |
| Other shareholders' equity | -313,300 | -239,600 | -200,600 | -159,400 | -139,400 |
| TOTAL | $10,686,100 | $10,744,500 | $11,289,200 | $12,536,900 | $13,339,100 |
| Total Liabilities And Equity | $24,618,900 | $24,934,100 | $25,511,800 | $26,119,200 | $27,234,300 |